Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsShortsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

GNLX

GENELUX Corp

CIK 0001231457 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$2.72
↓ 0.02 (-0.73%)
as of Aug 21, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Ownership; Risks: Fundamentals, Technicals; Excluded: Options (no data)

Key stats

Market Cap
$121.97M
P/E Ratio
-3.43
EPS
-0.86
Dividend Yield
Not covered
52W Position
7%
Beta
2.25

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
7.57
P/S
Not covered
EV/Revenue
Not covered
ROE
-220.9%
Valuation data covers 8,711/9,697 US-listed stocks (89.8%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 7%
$2.29$8.54

Latest Financials

2025-12-31 FY
Revenue
$8.00K
Net Income
-$32.15M
Total Assets
$19.03M
Free Cash Flow
-$26.37M

Recent news